$MLYS insider trading
Over the last 12 months, Mineralys Therapeutics insiders reported 1 buy totaling $8.8M and 39 sales totaling $84.1M across SEC Form 4 filings. 85% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $8.8M 1 event
- Sold · 12m
- $84.1M 39 events
- Events · 12m
- 40 Form 4 filings, grouped
- Insiders · 12m
- 8 distinct reporters
- 10b5-1 share
- 85% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Warren EricChief Commercial Officer · O | ▼ Sale | 7,437 | $25.98 | $193K | -16.2% | plan |
| Aug 10, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 2,170 | $27.09 | $59K | -4.1% | plan |
| Jul 21, 2026 | Warren EricChief Commercial Officer · O | ▼ Sale | 7,438 | $26.87 | $200K | -16.2% | plan |
| Jul 17, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 416 | $26.53 | $11K | -0.8% | plan |
| Jul 15, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 20,407 | $27.28 | $557K | -28.4% | plan · 2 tranches |
| Jul 13, 2026 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 10,700 | $27.24 | $291K | -1.7% | plan |
| Jul 9, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 2,171 | $30.3 | $66K | -3.6% | plan |
| Jun 30, 2026 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 75,000 | $26.14 | $2.0M | -10.9% | plan · 2 tranches |
| Jun 26, 2026 | Warren EricChief Commercial Officer · O | ▼ Sale | 104,124 | $25.9 | $2.7M | -73.1% | plan |
| Jun 17, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 14,474 | $24.19 | $350K | -20.2% | plan · 2 tranches |
| Jun 17, 2026 | Karydas DaphneD | ▼ Sale | 3,000 | $25 | $75K | -32.6% | plan |
| Jun 12, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 8,519 | $24.2 | $206K | -11.8% | plan · 2 tranches |
| Apr 17, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 416 | $31.33 | $13K | -0.6% | plan |
| Apr 15, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 20,406 | $26.89 | $549K | -22.6% | plan · 2 tranches |
| Apr 13, 2026 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 15,730 | $26.83 | $422K | -2.2% | plan |
| Apr 9, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 2,170 | $27.38 | $59K | -2.8% | plan |
| Mar 31, 2026 | Karydas DaphneD | ▼ Sale | 3,000 | $25 | $75K | -32.6% | plan |
| Mar 31, 2026 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 75,000 | $26.27 | $2.0M | -9.6% | plan · 3 tranches |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P.D | ▲ Buy | 369,000 | $23.75 | $8.8M | +6.8% | 2 tranches · indirect |
| Mar 17, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 417 | $25.65 | $11K | -0.5% | plan |
| Mar 13, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 20,406 | $26.61 | $543K | -21.1% | plan · 4 tranches |
| Mar 9, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 2,171 | $26.84 | $58K | -2.6% | plan |
| Feb 17, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 417 | $27.59 | $12K | -0.9% | plan |
| Feb 13, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 20,404 | $27.93 | $570K | -31.6% | plan · 5 tranches |
| Feb 9, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 2,171 | $30.21 | $66K | -4.1% | plan |
| Jan 20, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 416 | $32.1 | $13K | -0.8% | plan |
| Jan 14, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 19,076 | $32.66 | $623K | -27.4% | plan · 2 tranches |
| Jan 12, 2026 | Levy Adam ScottCFO and Secretary · O | ▼ Sale | 10,758 | $32.14 | $346K | -55.5% | plan |
| Jan 12, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 8,518 | $32.56 | $277K | -12.1% | plan · 2 tranches |
| Jan 12, 2026 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 16,236 | $32.62 | $530K | -2.5% | plan · 2 tranches |
| Jan 5, 2026 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 262,752 | $35.25 | $9.3M | -81% | plan · 3 tranches |
| Nov 20, 2025 | Slingsby Brian TaylorD·10% | ▼ Sale | 1,000,000 | $43.35 | $43.4M | -11.2% | indirect |
| Nov 13, 2025 | Karydas DaphneD | ▼ Sale | 15,000 | $45.99 | $690K | -100% | 2 tranches |
| Nov 13, 2025 | Gold Alexander MD | ▼ Sale | 34,675 | $45.45 | $1.6M | -100% | 5 tranches |
| Nov 11, 2025 | Levy Adam ScottCFO and Secretary · O | ▼ Sale | 119,524 | $44.88 | $5.4M | -86% | 9 tranches |
| Nov 11, 2025 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 200,000 | $45.44 | $9.1M | -24.1% | 6 tranches |
| Oct 15, 2025 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 10,369 | $43.01 | $446K | -12.7% | plan |
| Oct 13, 2025 | Levy Adam ScottCFO and Secretary · O | ▼ Sale | 10,758 | $42.01 | $452K | -8.4% | plan · 2 tranches |
| Oct 13, 2025 | Congleton JonChief Executive Officer · O·D | ▼ Sale | 15,100 | $42.67 | $644K | -1.8% | plan · 2 tranches |
| Sep 15, 2025 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 11,367 | $36 | $409K | -12.2% | plan · 2 tranches |
| Sep 4, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 588,235 | $25.5 | $15.0M | — | indirect |
| Sep 4, 2025 | RA CAPITAL MANAGEMENT, L.P.D | ▲ Buy | 1,176,470 | $25.5 | $30.0M | +27.5% | indirect |
| Aug 13, 2025 | Rodman David MalcomChief Medical Officer · O | ▼ Sale | 11,365 | $12.93 | $147K | -10.9% | plan |
Every $MLYS filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Mineralys Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MLYS feed.